Literature DB >> 1437720

Localization of neurokinin B in the central nervous system of the rat.

I Merchenthaler1, J L Maderdrut, F O'Harte, J M Conlon.   

Abstract

The distribution of neurokinin B (NKB) was determined by immunocytochemistry with antisera directed toward its amino terminus. Immunoreactive perikarya were detected in the main and accessory olfactory bulbs, cortical regions, the olfactory tubercle, the bed nucleus of the stria terminalis, the diagonal band of Broca, the nucleus accumbens, the septum, the neostriatum, several hypothalamic nuclei, the superior colliculus, the central gray, the substantia nigra, the medullary reticular formation, and the external cuneate nucleus. The distribution of NKB-containing perikarya revealed by immunocytochemistry was similar to the distribution of protachykinin B-containing cells previously visualized by in situ hybridization. Immunoreactive nerve fibers and terminals were detected in all major subdivisions of the brain. The levels of NKB measured by radioimmunoassay were highest in the hypothalamus. The distribution of NKB in the rat brain was similar to the distribution of substance P; however, there were several regions where the two distributions were clearly different.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437720     DOI: 10.1016/0196-9781(92)90192-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

Review 1.  Tachykinins and excitotoxicity in cerebellar granule cells.

Authors:  Cinzia Severini; Cristina Zona
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

Review 2.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

3.  Modulation of hypoglossal motoneuron excitability by NK1 receptor activation in neonatal mice in vitro.

Authors:  K Yasuda; D M Robinson; S R Selvaratnam; C W Walsh; A J McMorland; G D Funk
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

Review 4.  Neurokinin B and the hypothalamic regulation of reproduction.

Authors:  Naomi E Rance; Sally J Krajewski; Melinda A Smith; Marina Cholanian; Penny A Dacks
Journal:  Brain Res       Date:  2010-08-25       Impact factor: 3.252

5.  The tachykinin peptide neurokinin B binds copper forming an unusual [CuII(NKB)2] complex and inhibits copper uptake into 1321N1 astrocytoma cells.

Authors:  Debora Russino; Elle McDonald; Leila Hejazi; Graeme R Hanson; Christopher E Jones
Journal:  ACS Chem Neurosci       Date:  2013-08-07       Impact factor: 4.418

6.  Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Authors:  O Piot; J Betschart; I Grall; S Ravard; C Garret; J C Blanchard
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  Activation of tachykinin, neurokinin 3 receptors affects chromatin structure and gene expression by means of histone acetylation.

Authors:  Amit Thakar; Elise Sylar; Francis W Flynn
Journal:  Peptides       Date:  2012-09-15       Impact factor: 3.750

8.  Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.

Authors:  P Picard; D Regoli; R Couture
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

9.  Blockade of NK3R signaling in the PVN decreases vasopressin and oxytocin release and c-Fos expression in the magnocellular neurons in response to hypotension.

Authors:  Gwendolen E Haley; Francis W Flynn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-23       Impact factor: 3.619

10.  Forebrain projections of arcuate neurokinin B neurons demonstrated by anterograde tract-tracing and monosodium glutamate lesions in the rat.

Authors:  S J Krajewski; M C Burke; M J Anderson; N T McMullen; N E Rance
Journal:  Neuroscience       Date:  2009-12-28       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.